VLAP

Valneva Notizie

Acquistare
Vendere
Le migliori offerte per accedere ai dati in tempo reale
Euronext
Sottoscrizione Mensile
per soli
11,81 €
Book Euronext
Sottoscrizione Mensile
per soli
22,17 €
World Trader
Sottoscrizione Mensile
per soli
72,38 €
Prezzi IVA esclusa
Nome Azione Simbolo Borsa Mercato Tipo ISIN Descrizione
Valneva SE VLAP Euronext Azione Ordinaria FR0011472943 PRF PERPETUAL EUR
  Variazione Variazione % Quotazione Attuale Ora
0,00 0,0% 0,07 01:00:00
Apertura Min Max Prezzo di chiusura Chiusura
0,07
quotazione »

Ultime notizie

Data Ora Fonte Titolo
10/11/202017:45GLOBEValneva Announces Plans for Extraordinary General Meeting to..
03/11/202007:00GLOBEValneva Reports Nine Month Results Marked by Further Major..
20/10/202018:45GLOBEValneva Announces Positive Initial Results for Second Phase..
16/10/202007:00GLOBEValneva’s Chikungunya Vaccine Candidate Awarded EMA Prime..
18/9/202007:00GLOBEValneva Announces Retirement of Chief Financial Officer..
14/9/202007:00GLOBEValneva and Dynavax Announce Commercial Supply Agreement for..
09/9/202018:30GLOBEValneva Announces New IXIARO® Supply Contract with the US..
08/9/202007:00GLOBEValneva Initiates Phase 3 Clinical Study for its Chikungunya..
06/8/202007:00GLOBEValneva Announces Appointment of Juan Carlos Jaramillo as..
04/8/202007:00GLOBEValneva Reports H1 Results Marked by Major Corporate..
22/7/202018:45GLOBEValneva Announces Positive Initial Results for Phase 2 Study..
20/7/202007:00GLOBEValneva Confirms Participation in UK Government COVID-19..
18/6/202007:19GLOBEValneva and Bavarian Nordic Announce Marketing and..
17/6/202018:15GLOBEValneva Announces Successful Outcome of its AGM and the..
15/6/202007:00GLOBEBatavia Biosciences and Valneva Collaborate to Accelerate..
08/6/202018:00GLOBEValneva announces HSR clearance for Lyme vaccine..
02/6/202017:45GLOBEValneva Announces Publication in The Lancet of Complete..
07/5/202007:00GLOBEValneva Reports Q1 Results and Updates 2020 Guidance..
05/5/202017:45GLOBEValneva to Partner with Instituto Butantan on Single-Shot..
30/4/202007:00GLOBEValneva and Pfizer Announce Collaboration to Co-Develop and..
22/4/202022:00GLOBEValneva and Dynavax Announce Collaboration to Advance..
25/3/202018:30GLOBEValneva Reports Positive End-of-Phase 2 Chikungunya Meeting..
24/3/202007:00GLOBEValneva Provides Business Update on COVID-19 Situation
08/3/202019:00GLOBEValneva Announces FDA Approval of IXIARO® Shelf Life..
27/2/202007:00GLOBEValneva Reports Record Product Sales and Major Pipeline..
03/2/202022:30GLOBEValneva Announces New $85 Million Financing Arrangement with..
14/1/202007:00GLOBEValneva: US DoD Exercises Option on IXIARO® Supply Contract..
07/1/202017:45GLOBEValneva Announces End of Phase 2 Meeting with the FDA for..
12/12/201922:45GLOBEValneva Appoints MVM Partner Thomas Casdagli to its..
09/12/201917:40GLOBEValneva Appoints Renowned Vaccinologists Stanley Plotkin and..
05/12/201917:45GLOBEValneva to Conduct Investor and Partnering Meetings during..
28/11/201907:00GLOBEValneva Announces EMA Approval of IXIARO® Shelf Life..
Accedi alle altre notizie sul titolo »
La tua Cronologia
EU
VLAP
Valneva
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20201125 10:45:01